127 related articles for article (PubMed ID: 9115747)
21. Tyrosine kinase-dependent calcium signaling in airway smooth muscle cells.
Tolloczko B; Tao FC; Zacour ME; Martin JG
Am J Physiol Lung Cell Mol Physiol; 2000 Jun; 278(6):L1138-45. PubMed ID: 10835318
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle.
Di Salvo J; Steusloff A; Semenchuk L; Satoh S; Kolquist K; Pfitzer G
Biochem Biophys Res Commun; 1993 Feb; 190(3):968-74. PubMed ID: 8439345
[TBL] [Abstract][Full Text] [Related]
23. Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries.
Toma C; Jensen PE; Prieto D; Hughes A; Mulvany MJ; Aalkjaer C
Br J Pharmacol; 1995 Mar; 114(6):1266-72. PubMed ID: 7620718
[TBL] [Abstract][Full Text] [Related]
24. Regulation of vascular and gastric smooth muscle contractility by pervanadate.
Laniyonu A; Saifeddine M; Ahmad S; Hollenberg MD
Br J Pharmacol; 1994 Oct; 113(2):403-10. PubMed ID: 7530569
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
Martinson EA; Scheible S; Presek P
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
[TBL] [Abstract][Full Text] [Related]
26. Antispasmodic and myorelaxant effects of the flavoring agent methyl cinnamate in gut: potential inhibition of tyrosine kinase.
Lima FJ; Cosker F; Brito TS; Ribeiro-Filho HV; Silva CM; Aragão KS; Lahlou S; Souza MH; Santos AA; Magalhães PJ
Eur J Pharmacol; 2014 Oct; 740():192-9. PubMed ID: 25046838
[TBL] [Abstract][Full Text] [Related]
27. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle.
Abebe W; Agrawal DK
J Cardiovasc Pharmacol; 1995 Jul; 26(1):153-9. PubMed ID: 7564357
[TBL] [Abstract][Full Text] [Related]
28. Effects of inhibitors for tyrosine kinase and non-selective cation channel on capacitative Ca(2+) entry in rat ileal smooth muscle.
Ohta T; Yasuda W; Hasegawa A; Ito S; Nakazato Y
Eur J Pharmacol; 2000 Jan; 387(2):211-20. PubMed ID: 10650162
[TBL] [Abstract][Full Text] [Related]
29. The role of tyrosine kinase in prostaglandin E2 and vanadate-evoked contractions in rabbit duodenum in vitro.
Grasa L; Arruebo MP; Plaza MA; Murillo MD
J Physiol Pharmacol; 2006 Jun; 57(2):279-89. PubMed ID: 16845231
[TBL] [Abstract][Full Text] [Related]
30. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H
FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739
[TBL] [Abstract][Full Text] [Related]
31. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro.
Wong WS; Koh DS; Koh AH; Ting WL; Wong PT
J Pharmacol Exp Ther; 1997 Oct; 283(1):131-7. PubMed ID: 9336317
[TBL] [Abstract][Full Text] [Related]
32. Regionally different influence of contractile agonists on isolated rat airway segments.
Van de Voorde J; Joos G
Respir Physiol; 1998 May; 112(2):185-94. PubMed ID: 9716302
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of fast sodium current in rabbit ventricular myocytes by protein tyrosine kinase inhibitors.
Wang Y; Wagner MB; Kumar R; Cheng J; Joyner RW
Pflugers Arch; 2003 Jul; 446(4):485-91. PubMed ID: 12719980
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: evidence for dual regulation by Src and EGFR kinases.
Du XL; Gao Z; Lau CP; Chiu SW; Tse HF; Baumgarten CM; Li GR
J Gen Physiol; 2004 Apr; 123(4):427-39. PubMed ID: 15024039
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine kinase inhibitors attenuate "capacitative" Ca2+ influx in rat pancreatic acinar cells.
Yule DI; Kim ET; Williams JA
Biochem Biophys Res Commun; 1994 Aug; 202(3):1697-704. PubMed ID: 8060359
[TBL] [Abstract][Full Text] [Related]
36. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine phosphorylation as a convergent pathway of heterotrimeric G protein- and rho protein-mediated Ca2+ sensitization of smooth muscle of rabbit mesenteric artery.
Sasaki M; Hattori Y; Tomita F; Moriishi K; Kanno M; Kohya T; Oguma K; Kitabatake A
Br J Pharmacol; 1998 Dec; 125(8):1651-60. PubMed ID: 9886756
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of genistein on ATP-sensitive K+ channels in rabbit portal vein smooth muscle.
Ogata R; Kitamura K; Ito Y; Nakano H
Br J Pharmacol; 1997 Dec; 122(7):1395-404. PubMed ID: 9421287
[TBL] [Abstract][Full Text] [Related]
40. Essential role of L-arginine uptake and protein tyrosine kinase activity for NO-dependent vasorelaxation induced by stretch, isometric tension and cyclic AMP in rat pulmonary arteries.
Hucks D; Khan NM; Ward JP
Br J Pharmacol; 2000 Dec; 131(7):1475-81. PubMed ID: 11090123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
